Inactive Instrument

NPS Pharmaceuticals, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

12/15/12	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/15/26	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

12/15/12	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/15/26	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE
15/15/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE
13/15/13	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
17/14/17	AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	RE
02/14/02	NPS Pharmaceuticals : Shire secures $5 billion funding for NPS Pharma bid - The Times	RE

21/15/21	NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	PR
06/15/06	NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	PR
24/15/24	NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	BU
17/15/17	NPS Pharmaceuticals : NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc	BU
14/15/14	NPS Pharmaceuticals : NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc	BU

12/15/12	Shire : Hausse du résultat du T4, le titre monte
26/15/26	American Airlines : Les valeurs à suivre sur les marchés américains
26/15/26	USA-Les valeurs à suivre à Wall Street
13/15/13	Foundation Medicine : Wall Street clôture en baisse avec le pétrole
13/15/13	Wall Street finit en baisse avec le pétrole

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-6.60%	-8.56%	+49.38%	+64.90%	6.5TCr
LONZA GROUP AG	+0.03%	+5.56%	+9.10%	+75.22%	5.12TCr
ARGENX SE	-4.09%	-0.11%	+2.22%	+55.67%	5.12TCr
IQVIA HOLDINGS INC.	-1.53%	+2.70%	+30.48%	+41.25%	4.39TCr
BEONE MEDICINES AG	-1.34%	+4.12%	+16.64%	+120.28%	4.2TCr
REVOLUTION MEDICINES, INC.	-5.97%	-6.22%	+228.95%	+483.48%	3.81TCr
CELLTRION, INC.	+6.53%	+8.02%	+16.40%	+56.32%	3.32TCr
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	+1.80%	2.52TCr
GENMAB A/S	-1.07%	+2.33%	+19.43%	+20.40%	2.25TCr
Average	-1.66%	-0.35%	+45.52%	+102.15%	4.14TCr
Weighted average by Cap.	-2.20%	-0.50%	+44.25%	+103.65%

Employees

Sector